Victoria Ennen,Can Gollmann-Tepeköylü,Udo Wagner et al.
Victoria Ennen et al.
Kristians Meidrops,Saeid Hosseini,Pēteris Stradiņš et al.
Kristians Meidrops et al.
The pitfalls of transcatheter tricuspid valve repair: what we have learned in our last decade of experience [0.03%]
经导管三尖瓣修复的陷阱：过去十年经验教训
Silvia Corona,Walid Ben-Ali,Stephan von Bardeleben
Silvia Corona
The value of preoperative risk scores prior to tricuspid valve interventions: The TRI-SCORE and beyond [0.03%]
三尖瓣干预术前风险评分的价值：TRI-SCORE及其以外的内容
Julien Dreyfus,David Messika-Zeitoun
Julien Dreyfus
Tricuspid regurgitation (TR) is increasingly recognized as a condition associated with poor clinical outcomes, including reduced quality of life, progressive right-sided heart failure, and increased mortality. Its heterogeneous etiologies a...
Three decades evolution of the lifetime management approach to tricuspid valve disease: a multidisciplinary European perspective from a high-volume heart valve center [0.03%]
三尖瓣疾病终生管理方法的三十年演变——来自高容量心脏瓣膜中心的欧洲多学科视角
Piotr Mazur,Konstantinos Papakonstantinou,Mateo Marin-Cuartas et al.
Piotr Mazur et al.
Background: The treatment of tricuspid valve (TV) disease has increased over the last decades. This study evaluates trends, patient characteristics, and outcomes of surgical and transcatheter TV interventions over 30 year...
Innovations in transcatheter tricuspid valve interventions: what has failed, what has worked, what is coming [0.03%]
经导管三尖瓣介入治疗的创新：哪些失败了，哪些成功了，哪些即将到来
Matteo Sturla,Andrea Scotti,Azeem Latib
Matteo Sturla
Innovation in transcatheter tricuspid valve intervention has advanced by learning from what did not work and expanding what does. Early attempts, often adapted from the mitral space, exposed practical constraints and safety tradeoffs that u...
Outcomes after tricuspid transcatheter edge-to-edge repair: a systematic review and meta-analysis [0.03%]
三尖瓣经导管边对边修复的结局：系统评价和meta分析
Sara Bombace,Federico Fortuni,Edoardo Zancanaro et al.
Sara Bombace et al.
Background: Severe tricuspid regurgitation (TR) is associated with high morbidity and mortality. Tricuspid transcatheter edge-to-edge repair (T-TEER) improves TR severity and symptoms, yet survival benefit remains uncerta...
Tricuspid valve surgery in patients with concomitant left-sided valve disease [0.03%]
合并有左心瓣膜病的三尖瓣手术
Zara Dietze,Mateo Marin-Cuartas,Philipp Kiefer et al.
Zara Dietze et al.
Tricuspid valve endocarditis in people who inject drugs: strategies to reduce mortality and recurrent infection [0.03%]
如何减少吸毒者三尖瓣内膜炎的复发和死亡率
Suzanne de Waha,Thilo Noack,Tobias Kister et al.
Suzanne de Waha et al.
Tricuspid valve infective endocarditis (TV-IE) in people who inject drugs (PWID) has become an increasingly important clinical and public health concern, driven largely by the expanding opioid epidemic. Although PWID with TV-IE are typicall...
Macit Bitargil,Mohammad Alomari,Osama Haddad et al.
Macit Bitargil et al.
Background: Tricuspid regurgitation (TR) is common following heart transplant (HTx). Data on the outcomes of tricuspid valve (TV) surgery after HTx is limited. This study evaluates the short- and long-term outcomes of TV ...